Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis
Abstract Background The effect of inhaled corticosteroids (ICS) on risk of hyperglycemia in patients with chronic obstructive pulmonary disease (COPD) remains ambiguous. The aim of this study is to evaluate the association between ICS use and the incidence of hyperglycemia related adverse effects in...
Main Authors: | Xiaofeng Pu, Liang Liu, Bimin Feng, Zhengji Zhang, Guojun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-021-01789-7 |
Similar Items
-
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT
by: Graham Devereux, et al.
Published: (2019-07-01) -
Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
by: Cheng SL
Published: (2018-09-01) -
Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies
by: Lodise TP, et al.
Published: (2020-11-01) -
Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care
by: Savran O, et al.
Published: (2020-04-01) -
Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short
by: Tantucci C, et al.
Published: (2020-04-01)